After the discovery of BRCA1 and BRCA2, the highly penetrant breast (BC) and ovarian cancer (OC) predisposing genes, it became evident that about 20% of hereditary BC and/or OC syndrome families did not carry pathogenic variants in these genes. The gene discussed is BRCA2; the disease is breast cancer.